Ichor Holdings, Ltd. (NASDAQ:ICHR – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $46.60.
A number of equities research analysts have commented on the company. TD Cowen raised their target price on Ichor from $42.00 to $48.00 and gave the company a “buy” rating in a report on Wednesday, May 8th. B. Riley upgraded shares of Ichor from a “neutral” rating to a “buy” rating and upped their target price for the stock from $40.00 to $48.00 in a research report on Friday, April 19th. Stifel Nicolaus lifted their price target on shares of Ichor from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Tuesday, April 16th. Needham & Company LLC restated a “hold” rating and issued a $42.00 price target on shares of Ichor in a report on Wednesday, May 8th. Finally, Craig Hallum reduced their price objective on Ichor from $55.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, May 8th.
Get Our Latest Stock Analysis on ICHR
Insider Activity at Ichor
Institutional Investors Weigh In On Ichor
Hedge funds have recently modified their holdings of the company. FMR LLC boosted its position in Ichor by 9.4% during the third quarter. FMR LLC now owns 3,103,779 shares of the technology company’s stock worth $96,093,000 after acquiring an additional 265,677 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Ichor by 6.6% during the first quarter. Vanguard Group Inc. now owns 2,841,622 shares of the technology company’s stock worth $109,743,000 after purchasing an additional 176,970 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Ichor by 3.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,764,749 shares of the technology company’s stock worth $59,350,000 after purchasing an additional 56,725 shares during the last quarter. Swedbank AB purchased a new stake in shares of Ichor in the first quarter valued at $67,106,000. Finally, Hood River Capital Management LLC acquired a new position in Ichor in the first quarter valued at $36,971,000. 94.81% of the stock is owned by institutional investors and hedge funds.
Ichor Trading Up 0.9 %
NASDAQ ICHR opened at $39.65 on Wednesday. The firm’s fifty day moving average price is $38.10 and its 200 day moving average price is $38.01. Ichor has a 12 month low of $22.26 and a 12 month high of $46.43. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.16 and a quick ratio of 1.78. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of -22.40 and a beta of 1.94.
Ichor (NASDAQ:ICHR – Get Free Report) last announced its earnings results on Tuesday, May 7th. The technology company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.13) by ($0.04). Ichor had a negative return on equity of 2.93% and a negative net margin of 6.61%. The business had revenue of $201.38 million for the quarter, compared to analyst estimates of $200.00 million. On average, sell-side analysts expect that Ichor will post -0.2 earnings per share for the current fiscal year.
Ichor Company Profile
Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment in the United States and internationally. It primarily offers gas and chemical delivery systems and subsystems that are used in the manufacturing of semiconductor devices.
Read More
- Five stocks we like better than Ichor
- Investing In Preferred Stock vs. Common Stock
- RXO Shares Surge Following New Acquisition Deal
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Where Do I Find 52-Week Highs and Lows?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Ichor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ichor and related companies with MarketBeat.com's FREE daily email newsletter.